Nicolas Collongues

7.4k total citations
105 papers, 2.7k citations indexed

About

Nicolas Collongues is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Nicolas Collongues has authored 105 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pathology and Forensic Medicine, 61 papers in Neurology and 21 papers in Rheumatology. Recurrent topics in Nicolas Collongues's work include Multiple Sclerosis Research Studies (72 papers), Peripheral Neuropathies and Disorders (47 papers) and Systemic Lupus Erythematosus Research (15 papers). Nicolas Collongues is often cited by papers focused on Multiple Sclerosis Research Studies (72 papers), Peripheral Neuropathies and Disorders (47 papers) and Systemic Lupus Erythematosus Research (15 papers). Nicolas Collongues collaborates with scholars based in France, United States and Switzerland. Nicolas Collongues's co-authors include J. de Sèze, Frédéric Blanc, Sandra Vukusic, Hélène Zéphir, Caroline Papeix, Romain Marignier, Jean‐Baptiste Chanson, Kévin Bigaut, Laurent Kremer and Marie Fleury and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Nicolas Collongues

101 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Collongues France 28 2.0k 1.6k 523 405 290 105 2.7k
Caroline Papeix France 26 1.9k 1.0× 1.2k 0.8× 414 0.8× 367 0.9× 316 1.1× 111 2.7k
Paulus Rommer Austria 34 2.4k 1.2× 1.7k 1.0× 664 1.3× 294 0.7× 418 1.4× 172 3.7k
Ilya Kister United States 33 2.0k 1.0× 981 0.6× 382 0.7× 143 0.4× 346 1.2× 110 2.7k
Raffaele Iorio Italy 32 1.0k 0.5× 1.7k 1.0× 294 0.6× 307 0.8× 339 1.2× 126 2.9k
Marcelo Kremenchutzky Canada 23 2.3k 1.2× 944 0.6× 735 1.4× 111 0.3× 437 1.5× 64 2.9k
Jeannette Lechner‐Scott Australia 27 1.9k 1.0× 960 0.6× 399 0.8× 140 0.3× 313 1.1× 158 3.3k
Celia Oreja‐Guevara Spain 28 1.8k 0.9× 726 0.4× 342 0.7× 108 0.3× 340 1.2× 137 2.6k
Dejan Jakimovski United States 29 2.1k 1.1× 764 0.5× 511 1.0× 116 0.3× 310 1.1× 179 3.0k
Patrice H. Lalive Switzerland 34 1.0k 0.5× 1.0k 0.6× 251 0.5× 401 1.0× 321 1.1× 140 3.3k
B. Mark Keegan United States 31 2.0k 1.0× 2.0k 1.2× 653 1.2× 68 0.2× 262 0.9× 96 3.4k

Countries citing papers authored by Nicolas Collongues

Since Specialization
Citations

This map shows the geographic impact of Nicolas Collongues's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Collongues with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Collongues more than expected).

Fields of papers citing papers by Nicolas Collongues

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Collongues. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Collongues. The network helps show where Nicolas Collongues may publish in the future.

Co-authorship network of co-authors of Nicolas Collongues

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Collongues. A scholar is included among the top collaborators of Nicolas Collongues based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Collongues. Nicolas Collongues is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sèze, J. de, Chiara Zecca, Giovanni Castelnovo, et al.. (2025). European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?. Multiple Sclerosis Journal - Experimental Translational and Clinical. 11(1). 3120685010–3120685010. 2 indexed citations
2.
Bahougne, Thibault, Philippe Barthélémy, Lionnel Geoffrois, et al.. (2024). Central nervous system complications of immune checkpoint inhibitors: A comprehensive review. Critical Reviews in Oncology/Hematology. 206. 104595–104595. 7 indexed citations
3.
Kremer, Laurent, Marie Fleury, François Sellal, et al.. (2023). Early use of high efficacy therapies in pediatric forms of relapsing-remitting multiple sclerosis: A real-life observational study. Multiple Sclerosis and Related Disorders. 79. 104942–104942. 7 indexed citations
4.
Bigaut, Kévin, Laurent Kremer, Thibaut Fabacher, et al.. (2022). Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study. Journal of Neurology. 269(6). 3295–3300. 12 indexed citations
5.
Pique, Julie, Adil Maarouf, Xavier Ayrignac, et al.. (2022). Time to steroids impacts visual outcome of optic neuritis in MOGAD. Journal of Neurology Neurosurgery & Psychiatry. 94(4). 309–313. 18 indexed citations
6.
Khoury, Youssef El, J. de Sèze, Christine Patte‐Mensah, et al.. (2022). Rapid Discrimination of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis Using Machine Learning on Infrared Spectra of Sera. International Journal of Molecular Sciences. 23(5). 2791–2791. 8 indexed citations
7.
Bigaut, Kévin, Laurent Kremer, Thibaut Fabacher, et al.. (2021). Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies. Neurology Neuroimmunology & Neuroinflammation. 8(5). 23 indexed citations
8.
Bigaut, Kévin, et al.. (2021). Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection. Revue Neurologique. 177(10). 1237–1240. 21 indexed citations
9.
Papeix, Caroline, Élisabeth Maillart, J. de Sèze, et al.. (2020). A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteria. European Journal of Neurology. 27(11). 2250–2256. 3 indexed citations
10.
Louapre, Céline, Evelyne Maillart, Caroline Papeix, et al.. (2020). Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders. Multiple Sclerosis Journal. 26. 86–87. 4 indexed citations
11.
Bigaut, Kévin, Charles Paul Lambert, Laurent Kremer, et al.. (2020). Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal. 27(2). 232–238. 5 indexed citations
12.
Bigaut, Kévin, Thibaut Fabacher, Laurent Kremer, et al.. (2020). Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort. Multiple Sclerosis Journal. 27(5). 729–741. 11 indexed citations
13.
Louapre, Céline, Nicolas Collongues, Bruno Stankoff, et al.. (2020). Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. Multiple Sclerosis Journal. 26. 49–50. 84 indexed citations
14.
Khoury, Youssef El, Nicolas Collongues, J. de Sèze, et al.. (2019). Serum-based differentiation between multiple sclerosis and amyotrophic lateral sclerosis by Random Forest classification of FTIR spectra. The Analyst. 144(15). 4647–4652. 22 indexed citations
15.
Collongues, Nicolas, Catherine Schmidt‐Mutter, Marc Debouverie, et al.. (2018). Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy. PLoS ONE. 13(1). e0191614–e0191614. 23 indexed citations
16.
Collongues, Nicolas, Bertrand Bourre, Damien Biotti, et al.. (2018). Disease activity during pregnancy in patients with AQP4-Ab positive, MOG-Ab positive or double negative NMOSD. Multiple Sclerosis Journal. 24. 541–541. 3 indexed citations
17.
Ayrignac, Xavier, Clarisse Carra‐Dallière, Mikaël Cohen, et al.. (2018). Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases. Multiple Sclerosis and Related Disorders. 28. 109–116. 8 indexed citations
18.
Collongues, Nicolas, David Brassat, Élisabeth Maillart, et al.. (2015). Efficacy of rituximab in refractory neuromyelitis optica. Multiple Sclerosis Journal. 22(7). 955–959. 55 indexed citations
19.
Collongues, Nicolas, et al.. (2014). Utilisation d’une banque de données auscultatoires : vers une école de l’auscultation. 20(2). 87–92. 1 indexed citations
20.
Marignier, Romain, Raphaël Bernard‐Valnet, Pascale Giraudon, et al.. (2013). Aquaporin-4 antibody–negative neuromyelitis optica. Neurology. 80(24). 2194–2200. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Papeix Breakdown of academic impact, for papers by Paulus Rommer Breakdown of academic impact, for papers by Ilya Kister Breakdown of academic impact, for papers by Raffaele Iorio Breakdown of academic impact, for papers by Marcelo Kremenchutzky Breakdown of academic impact, for papers by Jeannette Lechner‐Scott Breakdown of academic impact, for papers by Celia Oreja‐Guevara Breakdown of academic impact, for papers by Dejan Jakimovski Breakdown of academic impact, for papers by Patrice H. Lalive Breakdown of academic impact, for papers by B. Mark Keegan
Rankless by CCL
2026